Stockscreener 앱 받기
6.913
0.14%
-0.017
전일 마감가:
$6.93
열려 있는:
$6.92
하루 거래량:
360.41K
Relative Volume:
0.39
시가총액:
$605.58M
수익:
-
순이익/손실:
$-95.90M
주가수익비율:
-5.2371
EPS:
-1.32
순현금흐름:
$-79.09M
1주 성능:
+2.37%
1개월 성능:
+14.38%
6개월 성능:
+86.52%
1년 성능:
-15.82%
1일 변동 폭
$6.87
$7.00
1주일 범위
$6.2324
$7.07
52주 변동 폭
$1.865
$11.40
턴스 파마슈티컬스 Stock (TERN) Company Profile
명칭
Terns Pharmaceuticals Inc
전화
650-525-5535 EXT.101
주소
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
6.92 | 591.57M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.81 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.25 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.67 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
693.92 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
315.92 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
턴스 파마슈티컬스 Stock (TERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2024-10-31 | 개시 | Oppenheimer | Outperform |
| 2023-06-22 | 개시 | Mizuho | Buy |
| 2023-06-07 | 개시 | Jefferies | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-08 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-14 | 개시 | JMP Securities | Mkt Outperform |
| 2023-02-07 | 개시 | UBS | Buy |
| 2022-09-12 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-14 | 재개 | Goldman | Buy |
| 2021-03-02 | 개시 | Cowen | Outperform |
| 2021-03-02 | 개시 | Goldman | Buy |
| 2021-03-02 | 개시 | JP Morgan | Overweight |
모두보기
턴스 파마슈티컬스 주식(TERN)의 최신 뉴스
RSI Suggests Rebound May Be Near in Terns Pharmaceuticals Inc.CEO Change & Safe Entry Trade Reports - newsyoung.net
Terns Pharmaceuticals Inc. Nearing Breakout Level After BounceJuly 2025 Closing Moves & AI Driven Price Forecasts - thegnnews.com
Institutional Tools Highlight Unusual Flow in Terns Pharmaceuticals Inc.July 2025 Momentum & Real-Time Volume Triggers - beatles.ru
Terns Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Breakouts & Weekly High Return Opportunities - Newser
Key metrics from Terns Pharmaceuticals Inc.’s quarterly dataJuly 2025 Opening Moves & Technical Buy Zone Confirmations - Newser
Terns Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Setups & AI Enhanced Trading Signals - Newser
Can trapped investors hope for a rebound in Terns Pharmaceuticals Inc.July 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
Applying chart zones and confluence areas to Terns Pharmaceuticals Inc.July 2025 Price Swings & Consistent Growth Equity Picks - Newser
Sentiment analysis tools applied to Terns Pharmaceuticals Inc.2025 Risk Factors & Growth-Oriented Investment Plans - Newser
Best data tools to analyze Terns Pharmaceuticals Inc. stockMarket Sentiment Review & Growth Focused Investment Plans - Newser
Using AI based signals to follow Terns Pharmaceuticals Inc.July 2025 Setups & Weekly Watchlist for Hot Stocks - Newser
Multi asset correlation models including Terns Pharmaceuticals Inc.Weekly Market Outlook & Verified Swing Trading Watchlists - Newser
Is Terns Pharmaceuticals Inc. stock bottoming outJuly 2025 Spike Watch & High Yield Stock Recommendations - Newser
Is Terns Pharmaceuticals Inc. a play on infrastructure spendingWeekly Profit Report & Free Safe Capital Growth Stock Tips - thegnnews.com
Will earnings trigger a reversal in Terns Pharmaceuticals Inc.Weekly Investment Summary & Free Long-Term Investment Growth Plans - Newser
Terns Pharmaceuticals Inc. At Critical Juncture — Bounce or BreakdownPortfolio Profit Report & Technical Pattern Recognition Alerts - metal.it
Terns Pharmaceuticals Inc (TERN) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
What institutional flow reveals about Terns Pharmaceuticals Inc.Weekly Profit Analysis & AI Powered Market Entry Strategies - Newser
What makes Terns Pharmaceuticals Inc. stock price move sharplyMarket Activity Summary & Fast Gain Swing Alerts - Newser
Is It Too Late to Sell Terns Pharmaceuticals Inc.2025 Market Sentiment & Real-Time Market Sentiment Reports - classian.co.kr
Terns Pharmaceuticals’ SWOT analysis: obesity drug stock poised for pivotal data - Investing.com Nigeria
Terns Pharmaceuticals’ SWOT analysis: obesity drug stock poised for pivotal data By Investing.com - Investing.com South Africa
Analyzing Sangamo Therapeutics (NASDAQ:SGMO) & Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Analyzing drawdowns of Terns Pharmaceuticals Inc. with statistical toolsJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - Newser
Heatmap analysis for Terns Pharmaceuticals Inc. and competitorsLong Term Stock Planner with Safety Checks - Newser
Does Terns Pharmaceuticals Inc. show high probability of reboundFree Breakout Confirmation With Entry Tracker - Newser
Terns Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks
Custom strategy builders for tracking Terns Pharmaceuticals Inc.Downside Control Plan With Support Analysis - Newser
William Blair Has Positive Outlook of TERN FY2025 Earnings - Defense World
How Terns Pharmaceuticals Inc. stock performs during market volatilityFree Portfolio Diversification Stock Ideas - Newser
턴스 파마슈티컬스 (TERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
턴스 파마슈티컬스 주식 (TERN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Gengos Andrew | Chief Financial Officer |
Jun 27 '25 |
Buy |
3.93 |
10,000 |
39,283 |
25,000 |
| Burroughs Amy L. | Chief Executive Officer |
Jun 25 '25 |
Buy |
3.87 |
23,314 |
90,230 |
47,083 |
| Gengos Andrew | Chief Financial Officer |
Jun 13 '25 |
Buy |
3.73 |
10,000 |
37,350 |
10,000 |
| Gengos Andrew | Chief Financial Officer |
Jun 16 '25 |
Buy |
3.95 |
5,000 |
19,732 |
15,000 |
| Kuriakose Emil | Chief Medical Officer |
Apr 01 '25 |
Sale |
2.49 |
952 |
2,366 |
53,317 |
| Jung Melita Sun | Chief Business Officer |
Nov 30 '24 |
Buy |
5.11 |
2,250 |
11,498 |
2,250 |
| Burroughs Amy L. | Chief Executive Officer |
Nov 30 '24 |
Buy |
5.11 |
510 |
2,606 |
19,609 |
| Kuriakose Emil | Chief Medical Officer |
Jan 02 '25 |
Sale |
5.71 |
4,481 |
25,607 |
54,269 |
| Vignola Mark J. | Chief Financial Officer |
Jan 06 '25 |
Sale |
5.80 |
9,059 |
52,500 |
74,752 |
| Vignola Mark J. | Chief Financial Officer |
Jan 02 '25 |
Sale |
5.72 |
8,129 |
46,524 |
83,811 |
0.12%
0.57%
자본화:
|
볼륨(24시간):